文/梧桐小编 1月14日，四川证监局公布《关于对成都振芯科技股份有限公司及谢俊等相关责任人员采取出具警示函措施的决定》。经查，成都振芯科技股份有限公司 （300101）于2025年12月30日，通过非法定信息披露渠道发布控股股东可能对公司董事会提前换届信息，违反"公平原则"，损害投资者公平知情权，且上述信息 披露违反"真实、准确、完整"的要求。公司董事长谢俊、董事徐进、董事柏杰在发布信息上署名，公司董事兼总经理杨国勇、董事会秘书陈思莉在公司审批流程 中签字同意。同日，深交所针对该公司及5名董事的上述行为下发了《监管函》，认定公司董事长谢俊、董事徐进、董事柏杰、董事兼总经理杨国勇、董事会秘书 陈思莉未能恪尽职守、履行诚信勤勉义务，对该公司上述违规行为负有责任。深交所要求责任人充分重视上述问题，吸取教训，及时整改，杜绝上述问题的再次 发生。 | 索 引 号 | bm56000001/2026-00000514 | ਦੇ 崇 | 行政监管措施;上市公司监管 | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | 2026年01月14日 | | 80 称 | 关于对成都振芯科技股份 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 1 月 14 日，振芯科技同步披露收到中国证券监督管理委员会四川监管局《警示函》及深圳证券交易所监管函的相关情况，公司因通过非法定渠道违规披 露信息，相关责任人已被认定负有责任并面临监管追责。 根据监管文件查明的事实，振芯科技于 2025 年 12 月 30 日通过非法定信息披露渠道，发布了控股股东可能对公司董事会提前换届的相关信息。该行为不 仅违反了资本市场信息披露的 "公平原则"，损害了全体投资者的公平知情权，其披露的信息也未能满足 "真实、准确、完整" 的法定要求。 经查证，公司董事长谢俊、董事徐进、董事柏杰在该违规发布的信息上署名，公司董事兼总经理杨国勇、董事会秘书陈思莉则在相关信息的公司审批流程 中签字同意，上述五人均被认定为此次违规行为的相关责任人。 四川证监局指出，振芯科技的违规情形违反了《上市公司信息披露管理办法》（证监会令第 226 号）第五条第二款规定，相关责任人的行为已构成违规。 依据《上市公司信息披露管理办法》第五十二条、第五十三条规定，四川证监局对公司及谢俊、徐进、柏杰、杨国勇、陈思莉采取出具警示函的行政监管 措施，并将相关情况记入证 ...

上交所公告，2025年12月5日，瑞茂通供应链管理股份有限公司披露《关于部分债务逾期及部分账户被 冻结的公告》显示，截至公告披露日，公司逾期债务本金合计10.93亿元，占公司最近一期经审计净资 产的13.86%。其中，2025年11月19日至11月22日期间，公司逾期债务本金合计金额已超过净资产的 10%，达到应当披露的标准，但公司迟至12月5日才披露公告，相关信息披露不及时。鉴于上述违规事 实和情节，对瑞茂通供应链管理股份有限公司及时任董事长万永兴、时任总经理胡磊、时任财务总监刘 建辉、时任董事会秘书张菊芳予以监管警示。 ...

Group 1 - The core issue is that Zhenxin Technology (振芯科技) received warning letters from both the Sichuan Securities Regulatory Bureau and the Shenzhen Stock Exchange for violating information disclosure regulations by releasing information through unauthorized channels, which harmed investors' rights to fair information [1][2] - The warning letters highlighted that the company disclosed information regarding the potential early replacement of the board of directors by the controlling shareholder, violating principles of fairness and the requirements for truthful, accurate, and complete disclosures [1][2] - The company and five responsible individuals, including the chairman and other board members, are held accountable for these violations under the relevant regulations, and the incidents will be recorded in the securities market integrity archives [1][2] Group 2 - Zhenxin Technology acknowledged the issues raised in the warning letters and committed to improving its governance and information disclosure practices to prevent similar incidents in the future [2] - The company stated that the administrative regulatory measures would not affect its normal production and management activities, and it would continue to fulfill its disclosure obligations in accordance with legal requirements [2] - The company operates in high-performance integrated circuits, Beidou navigation applications, machine perception and intelligence, and smart city construction and operation services [2] Group 3 - Financial reports indicate that Zhenxin Technology's performance has declined for two consecutive years, with net profit growth rates of -75.81% and -44.91% for 2023 and 2024, respectively [3] - The net profits for the last two years were 72.6 million yuan and 40 million yuan, significantly lower than the 300 million yuan net profit in 2022 [3] - The company's Q3 2025 report showed total revenue of 736 million yuan, a year-on-year increase of 30.56%, and a net profit attributable to shareholders of 9.28 million yuan, also up by 30.79% [3]

Core Viewpoint - Zhejiang Sunflower (stock code: 300111) has received a notice from the China Securities Regulatory Commission (CSRC) regarding potential administrative penalties for suspected violations of information disclosure laws [1] Group 1: Company Announcement - The company has stated that it has not yet received the final penalty decision from the CSRC, and the outcome will depend on the formal decision issued by the CSRC [1] - According to the Securities Law and relevant judicial interpretations, if a listed company causes investor losses due to false statements, it must bear civil compensation responsibilities [1] Group 2: Investor Compensation - Preliminary compensation scope includes investors who purchased Sunflower stock between its listing and before the market close on January 15, 2026, and still hold the stock at that time [2] - Investors are required to prepare specific materials, including original transaction statements stamped by the brokerage, copies of their ID cards, and a securities account information query issued by the brokerage [3][4] Group 3: Legal Perspective - The preliminary registration conditions for compensation are based on publicly available information and relevant laws, and may be adjusted as regulatory investigations and judicial processes progress [5]

1 月 14 日，振芯科技同步披露收到中国证券监督管理委员会四川监管局《警示函》及深圳证券交易所监管函的相关情况，公司因通过非法定渠道违规披露 信息，相关责任人已被认定负有责任并面临监管追责。 针对此次监管措施，振芯科技董事会在公告中表示，公司及相关人员高度重视《警示函》中指出的问题，将认真总结教训，进一步加强对《上市公司信息披 露管理办法》《深圳证券交易所创业板股票上市规则》等相关法律法规及规范性文件的学习理解，提高公司治理水平，强化信息披露管理，避免类似事件再 次发生，切实维护公司及全体股东利益。同时公司明确，本次行政监管措施不会影响公司正常的生产经营管理活动，后续将严格按照法律法规规定，及时履 行信息披露义务。 根据监管文件查明的事实，振芯科技于 2025 年 12 月 30 日通过非法定信息披露渠道，发布了控股股东可能对公司董事会提前换届的相关信息。该行为不仅 违反了资本市场信息披露的 "公平原则"，损害了全体投资者的公平知情权，其披露的信息也未能满足 "真实、准确、完整" 的法定要求。 经查证，公司董事长谢俊、董事徐进、董事柏杰在该违规发布的信息上署名，公司董事兼总经理杨国勇、董事会秘书陈思莉则在相 ...

Core Viewpoint - The company麒盛科技 has faced regulatory scrutiny due to violations of information disclosure regulations, leading to corrective measures and warnings issued to its executives [1][2]. Group 1: Regulatory Actions - The company and its executives received warnings from the Zhejiang Securities Regulatory Bureau for failing to disclose related party transactions in a timely manner [1][2]. - The related party transactions with Shanghai Shufu De Digital Technology Co., Ltd. amounted to 35.31 million yuan in 2023 and 80.81 million yuan in 2024, representing 1.08% and 2.63% of the audited net assets for those years, respectively [1][2]. Group 2: Company Performance - For the first three quarters of 2025, the company reported total revenue of 2.224 billion yuan, a year-on-year increase of 0.08%, while net profit attributable to shareholders decreased by 2.74% to 147 million yuan [2]. - The company's net profit excluding non-recurring items fell by 11.89% to 149 million yuan [2]. Group 3: Shareholder Actions - The controlling shareholder,嘉兴智海投资管理有限公司, reduced its stake by 4.922 million shares (1.39% of total shares) through block trading between November 7 and November 21, 2025 [3]. - The actual controller and chairman唐国海 sold 3.45 million shares (0.98% of total shares) via centralized bidding on November 3, 2025, with total cash proceeds exceeding 150 million yuan [3]. - Prior to these transactions, company executives had also completed their share reduction plans, cashing out over 5.7 million yuan [3].

Core Viewpoint - The article highlights the ongoing stringent regulatory environment in China's stock market, with multiple companies facing penalties for financial misconduct, particularly focusing on ST Huilun's significant fines for financial fraud and related issues [1][4][10]. Group 1: Regulatory Actions and Penalties - On January 12, 2026, ST Huilun was fined 11.4 million for concealing related party fund occupation and committing financial fraud over two consecutive years [1][4]. - In the first nine working days of 2026, at least six listed companies received regulatory penalties or investigation notices, continuing the "zero tolerance" regulatory approach established in 2025 [1][7]. - In 2025, over 80 companies were investigated for information disclosure violations, with nearly 80 receiving administrative penalties, including 15 that faced mandatory delisting due to severe violations, marking a historical high [1][12]. Group 2: Specific Cases of Financial Misconduct - ST Huilun's penalties stemmed from related party fund occupation amounting to 28.33 million, which was not disclosed in annual reports, and subsequent financial fraud to cover up this issue [3][4]. - The company inflated its revenue by approximately 25.49 million in 2021 and 62.33 million in 2022, leading to false financial statements [3][4]. - Another company, Jushi Chemical, was penalized for financial fraud involving inflated revenue of 157 million and costs of 158 million in its 2023 semi-annual report [8]. Group 3: Trends in Regulatory Environment - The regulatory environment in 2026 is characterized by a continued emphasis on strict oversight, with expectations of a high number of penalties for violations [10][12]. - The types of violations leading to penalties are diverse, including not only financial fraud but also related party fund occupation and disclosure violations by controlling shareholders [10][12]. - The regulatory focus aims to promote timely rectification of issues within companies, enhancing overall market quality and reducing the number of penalized companies in the future [10][12].

Group 1 - The core point of the article highlights that ST Huilun (300460) has faced regulatory penalties due to violations in information disclosure, specifically related to financial report inaccuracies from 2020 to 2022 [1][2] - On January 13, 2026, ST Huilun's stock closed at 8.91 yuan, down 1.22%, with a turnover rate of 7.32% and a trading volume of 205,600 shares, amounting to a transaction value of 184 million yuan [1] - The company received a total fine of 3 million yuan from the China Securities Regulatory Commission (CSRC) for failing to disclose significant financial information and for fabricating revenue and costs in its financial reports [1][2] Group 2 - On January 13, 2026, the net outflow of main funds was 17.58 million yuan, while retail and speculative funds showed a net inflow [2] - The company has stated that it has returned the occupied funds and that its production and operations are normal, indicating that the penalties do not lead to a situation of mandatory delisting due to major violations [1]

Group 1 - The acquisition of Ruisheng Bio by Haili Bio has resulted in a significant valuation drop, with the company's estimated value reduced from 1.7 billion yuan to 974 million yuan due to performance decline [5][39] - Ruisheng Bio, identified as a "hidden champion" in Shaanxi Province, specializes in natural calcined bone repair materials and has established a leading market position in dental implant repair materials [5][39] - The financial performance of Ruisheng Bio has been questioned, particularly regarding its customer relationships, with a newly established company appearing as a major client before its official registration [6][9] Group 2 - Haili Bio acquired 55% of Ruisheng Bio for 935 million yuan, reflecting a 952% increase in value since the initial purchase of multiple companies, including Ruisheng Bio, for 35 million HKD [5][39] - The sales figures for Ruisheng Bio's major clients in 2022 and 2023 show discrepancies, with a significant portion of sales attributed to clients that were either newly established or claimed to have no prior relationship with Ruisheng Bio [8][20] - The investigation revealed that the actual business relationships and sales figures may not align with the disclosures made by Ruisheng Bio, raising concerns about potential financial misrepresentation [12][13] Group 3 - The competitive landscape in the dental implant market has intensified, leading to a drastic price drop of 50% to 60% for bone powder products, which has adversely affected Ruisheng Bio's revenue [38] - Despite a compound annual growth rate of 84.59% in revenue from 2021 to 2023, Ruisheng Bio reported a significant decline in revenue and profit in the third quarter of 2025 [37][38] - Haili Bio plans to expand its business by acquiring stakes in dental chain companies, which is expected to positively impact its revenue and profit in 2026 [39]